Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)

Clinical trial NCT01027884 · COMPLETED

Trial details

NCT number: NCT01027884
Sponsor: Santhera Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophy, Duchenne Ambulatory Care

Start date: 2009-07-01
Primary completion: 2014-01-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.